 SOUTH SAN FRANCISCO, Calif., July 09, 2021 GLOBE NEWSWIRE -- Global Blood Therapeutics, Inc. GBT NASDAQ: GBT today announced that on July 1, 2021, the compensation committee of GBTs board of directors granted 23 new employees options to purchase an aggregate of 9,600 shares of the companys common stock with a per share exercise price of 37.34 and restricted stock units for an aggregate of 94,320 shares of the companys common stock. These awards were made under GBTs Amended and Restated 2017 Inducement Equity Plan the Plan. 